REFERENCES
- Allen DB, Julius JR, Breen TJ, Attie KM. Treatment of glucocorticoid induced growth suppression with growth hormone. J Clin Endocrinol Metab 1998;83:2824–2829.
- Ballock RT, O'Keefe RJ. Physiology and pathophysiology of the growth plate. Birth Defects Res C Embryo Today 2003;69:123–143.
- Johnson RW. Inhibition of growth by pro-inflammatory cytokines: an integrated view. J Anim Sci 1997;75:1244–1255.
- Su XM, Yu N, Kong LF, Kang J. Effectiveness of inhaled corticosteroids in the treatment of acute asthma in children in the emergency department: a meta-analysis. Ann Med 2014;46(1):24–30.
- Soybilgic A, Tesher M, Wagner-Weiner L, Onel KB. A survey of steroid-related osteoporosis diagnosis, prevention and treatment practices of pediatric rheumatologists in North America. Pediatr Rheumatol Online J 2014;12:12–24.
- Rodd C, Lang B, Ramsay T, et al. Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study. Arthritis Care Res (Hoboken) 2012;64(1):122–131.
- Torres RL, Torres IL, Laste G, et al. Effects of acute and chronic administration of methylprednisolone on oxidative stress in rat lungs. J Bras Pneumol 2014;40(3):238–243.
- Sorkness RL, Remus JL, Rosenthal LA. Systemic and pulmonary effects of fluticasone administered through a metered-dose inhaler in rats. J Allergy Clin Immunol 2004;114:1027–1032.
- Vanacker NJ, Palmans E, Pauwels RA, Kips JC. Dose-related effect of inhaled fluticasone on allergen-induced airway changes in rats. Eur Respir J 2002;20:873–879.
- Long-term effects of budesonide or nedocromil in children with asthma. The childhood asthma management program research group. N Engl J Med 2000;12(343):1054–1063.
- Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000;343:1064–1069.
- Skoner DP, Szefler SJ, Welch M, et al. Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma. J Allergy Clin Immunol 2000;105:259–268.
- Roux C, Kolta S, Desfougeres JL, et al. Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma. Pediatrics 2003;111:e706–e713.
- Allen D, Bielory L, Derendorf H, et al. Inhaled corticosteroids: past lessons and future issues. J Allergy Clin Immunol 2003;112(3 Suppl):S1–S40.
- Iles R, Williams RM, Deeb A, et al. A longitudinal assessment of the effect of inhaled fluticasone propionate therapy on adrenal function and growth in young children with asthma. Pediatr Pulmonol 2008;43:354–359.
- Doull IJ, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med 1995;151:1715–1719.
- Verberne AA, Frost C, Roorda RJ, et al. One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group. Am J Respir Crit Care Med 1997;156:688–695.
- Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006;11(354):1985–1997.
- Ferguson AC, Van Bever HP, Teper AM, et al. A comparison of the relative growth velocities with budesonide and fluticasone propionate in children with asthma. Respir Med 2007;101:118–129.
- Ferguson AC, Spier S, Manjra A, et al. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide. J Pediatr 1999;134:422–4227.
- Acun C, Tomac N, Ermis B, Onk G. Effects of inhaled corticosteroids on growth in asthmatic children: a comparison of fluticasone propionate with budesonide. Allergy Asthma Proc 2005;26:204–206.
- Belvisi MG, Bundschuh DS, Stoeck M, et al. Preclinical profile of ciclesonide, a novel corticosteroid for the treatment of asthma. J Pharmacol Exp Ther 2005;314:568–574.
- Silvestrini G, Ballanti P, Patacchioli FR, Evaluation of apoptosis and the glucocorticoid receptor in the cartilage growth plate and metaphyseal bone cells of rats after high-dose treatment with corticosterone. Bone 2000;26:33–42.
- Abu EO, Horner A, Kusec V, et al. The localization of the functional glucocorticoid receptor alpha in human bone. J Clin Endocrinol Metab 2000;85:883–889.
- Zhang HF, Wang WP, Yang Y, et al. Dexamethasone up-regulates the expression of glucocorticoid receptor in growth plate and inhibits the longitudinal growth of bone: experiment with rats. Zhonghua Yi Xue Za Zhi 2007;25(87):2575–2577.
- Jux C, Leiber K, Hügel U, et al. Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH- and IGF-I-receptor in cultured rat chondrocytes. Endocrinology 1998;139:3296–3305.
- Chagin AS, Karimian E, Sundström K, et al. Catch-up growth after dexamethasone withdrawal occurs in cultured postnatal rat metatarsal bones. J Endocrinol 2010;204:21–29.
- Robson H, Anderson E, Eden O, et al. Glucocorticoid pretreatment reduces the cytotoxic effects of a variety of DNA-damaging agents on rat tibial growth-plate chondrocytes in vitro. Cancer Chemother Pharmacol 1998;42:171–176.
- Guenther HL, Felix R, Fleisch H. Comparative study of deflazacort, a new synthetic corticosteroid, and dexamethasone on the synthesis of collagen in different rat bone cell populations and rabbit articular chondrocytes. Calcif Tissue Int 1984;36:145–152.
- Ryrfeldt A, Edsbacker S, Pouwles R. Kinetics of epimeric glucocorticoid budesonide. Clin Pharmacol Therapeut 1984;35:525–530.
- Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990;84 suppl:25–29.
- Johnson M. Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids. J Allergy Clin Immunol 1996;97:169–176.